Advertisement
Screener

CEL-SCI CORPORATION (CVM) ROA

CEL SCI CORP ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CEL SCI CORP roa for the quarter ending 2026-06-30 was -106.31%, a change of 18.68% year-over-year.
  • CEL SCI CORP roa for the quarter ending 2026-03-31 was -128.20%, a change of -6.17% year-over-year.
  • CEL SCI CORP roa for the quarter ending 2025-12-31 was -103.99%, a change of 2.18% year-over-year.
  • CEL SCI CORP roa for the quarter ending 2025-09-30 was -90.25%, a change of 9.48% year-over-year.
  • CEL SCI CORP roa for fiscal 2025 was -90.25%, a change of 9.48% from fiscal 2024.
  • CEL SCI CORP roa for fiscal 2024 was -99.74%, a change of 6.28% from fiscal 2023.
  • CEL SCI CORP roa for fiscal 2023 was -106.02%, a change of -33.38% from fiscal 2022.
  • CEL SCI CORP roa for fiscal 2022 was -72.64%, a change of -24.71% from fiscal 2021.
Available history
2010-09-30 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-106.31%-$22.7M-$5.67M$21.36M
2026-03-31-128.20%-$22.7M-$5.47M$17.71M
2025-12-31-103.99%-$23.81M-$5.47M$22.89M
2025-09-30-90.25%-$25.41M-$6.10M$28.16M
2025-06-30-125.00%-$25.42M-$5.66M$20.34M
2025-03-31-122.03%-$26.61M-$6.57M$21.81M
2024-12-31-106.17%-$27.28M-$7.07M$25.7M
2024-09-30-99.74%-$26.92M-$6.11M$26.99M
2024-06-30-118.88%-$28.61M-$6.86M$24.07M
2024-03-31-100.25%-$30.12M-$7.24M$30.05M
2023-12-31-108.75%-$31.22M-$6.71M$28.71M
2023-09-30-106.02%-$32.37M-$7.80M$30.53M
2023-06-30-102.19%-$33.03M-$8.37M$32.32M
2023-03-31-89.78%-$34.29M-$8.34M$38.2M
2022-12-31-80.28%-$35.77M-$7.85M$44.56M
2022-09-30-72.64%-$36.7M-$8.46M$50.52M
2022-06-30-64.06%-$36.44M-$9.63M$56.89M
2022-03-31-55.72%-$35.75M-$9.82M$64.16M
2021-12-31-53.40%-$37.21M-$8.78M$69.67M
2021-09-30-47.93%-$36.36M-$8.20M$75.87M
2021-06-30-42.11%-$33.54M-$8.94M$79.64M
2021-03-31-72.11%-$34.87M-$11.28M$48.37M
2020-12-31-65.83%-$32.66M-$7.94M$49.61M
2020-09-30-74.64%-$30.26M-$5.38M$40.54M
2020-06-30-67.70%-$29.72M-$10.28M$43.91M
2020-03-31-86.04%-$31.53M-$9.07M$36.65M
2019-12-31-91.80%-$28.91M-$5.53M$31.49M
2019-09-30-80.13%-$22.13M-$4.85M$27.62M
2019-06-30-113.09%-$32.21M-$12.08M$28.48M
2019-03-31-105.61%-$26.14M-$6.45M$24.76M
2018-12-31-94.10%-$24.4M$1.25M$25.93M
2018-09-30-107.61%-$31.84M-$14.93M$29.59M
2018-06-30-100.94%-$21.9M-$6.01M$21.7M
2018-03-31-88.15%-$20.35M-$4.71M$23.09M
2017-12-31-108.56%-$24.07M-$6.19M$22.17M
2017-09-30-62.66%-$14.36M-$4.99M$22.92M
2017-06-30-48.10%-$10.5M-$4.46M$21.82M
2017-03-31-44.81%-$9.9M-$8.43M$22.08M
2016-12-31-44.40%-$10.32M$3.52M$23.25M
2016-09-30-46.26%-$11.51M-$1.13M$24.89M
2016-06-30-139.81%-$20.25M-$3.86M$14.48M
2016-03-31-134.12%-$20.81M-$8.86M$15.52M
2015-12-31-122.66%-$24.51M$2.33M$19.98M
2015-09-30-121.50%-$34.69M-$9.86M$28.55M
2015-06-30-149.05%-$32.04M-$4.43M$21.5M
2015-03-31-236.17%-$30.05M-$12.56M$12.73M
2014-12-31-157.85%-$30.86M-$7.85M$19.55M
2014-09-30-142.24%-$27.35M-$7.22M$19.23M
2014-06-30-86.83%-$21.84M-$2.44M$25.16M
2014-03-31-109.30%-$23.85M-$13.37M$21.82M
2013-12-31-45.15%-$11.2M-$4.33M$24.8M
2013-09-30-84.61%-$9.17M-$1.70M$10.84M
2013-06-30-68.05%-$10.04M-$4.45M$14.75M
2013-03-31-34.75%-$6.43M-$713.37K$18.49M
2012-12-31-64.54%-$14.21M-$2.31M$22.01M
2012-09-30-96.33%-$15.48M-$2.57M$16.07M
2012-06-30-76.43%-$15.23M-$835.45K$19.93M
2012-03-31-95.23%-$17.51M-$8.49M$18.38M
2011-12-31-138.16%-$23.04M-$3.58M$16.68M
2011-09-30-138.05%-$25.71M-$2.32M$18.63M
2011-06-30-129.41%-$30.73M-$3.11M$23.74M

Annual ROA

DateROANet income 12 monthTotal assets
2025-09-30-90.25%-$25.41M$28.16M
2024-09-30-99.74%-$26.92M$26.99M
2023-09-30-106.02%-$32.37M$30.53M
2022-09-30-72.64%-$36.7M$50.52M
2021-09-30-47.93%-$36.36M$75.87M
2020-09-30-74.64%-$30.26M$40.54M
2019-09-30-80.13%-$22.13M$27.62M
2018-09-30-107.61%-$31.84M$29.59M
2017-09-30-62.66%-$14.36M$22.92M
2016-09-30-46.26%-$11.51M$24.89M
2015-09-30-121.50%-$34.69M$28.55M
2014-09-30-142.24%-$27.35M$19.23M
2013-09-30-84.61%-$9.17M$10.84M
2012-09-30-96.33%-$15.48M$16.07M
2011-09-30-138.05%-$25.71M$18.63M
2010-09-3027.73%$10.48M$37.8M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
LeonaBio, Inc. (LONA)United States$0.047B-0.61